Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pharmaceutical Sciences"
DOI: 10.1016/j.ejps.2018.02.018
Abstract: &NA; Treatment of toxoplasmosis is necessary in congenital form and immunocompromised patients. Atovaquone is a powerful suppressor of protozoan parasites with a broadâspectrum activity, but an extremely low water solubility and bioavailability. In this study,… read more here.
Keywords: nanoemulsion atovaquone; atovaquone; treatment; toxoplasmosis ... See more keywords